Skip to main content
Equibles

BARCLAYS PLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$666,354
+$44,927 QoQ
Shares Held
508,668
+29.3% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 130 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. LCTX ranks #139 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in LCTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $666,354 508,668
2026-03-31 $621,427 393,309
2025-12-31 $582,011 348,510
2025-09-30 $1 1
2025-06-30 $24,059 26,439
2025-03-31 $87,770 195,045
2024-12-31 $117,034 234,069
2024-09-30 $192,283 211,300
2024-06-30 $51,376 51,376
2024-03-31 $139,011 93,927
2023-12-31 $199,788 183,292
2023-09-30 $28,315 23,996
2023-06-30 $36,526 25,905
2023-03-31 $20,745 13,830
2022-12-31 $32,887 28,109
2022-09-30 $8,629 7,637
2022-03-31 $31,354 20,360